Seroflo Rotacaps 100 Mcg (Salmeterol & Fluticasone)

Seroflo Rotacaps 100 mcg – Trusted Entry-Level Combination Therapy for Asthma Management Online

For patients with mild-to-moderate persistent asthma whose symptoms have moved beyond what a daily inhaled corticosteroid alone can comfortably manage, stepping up to a combination inhaler therapy represents a clinically logical and evidence-supported progression. Seroflo Rotacaps 100 mcg deliver exactly that transition — offering the entry-level strength of Cipla’s well-established fluticasone propionate and salmeterol combination in a convenient, breath-activated dry powder capsule format that addresses both the inflammatory and bronchospastic dimensions of asthma simultaneously through a single, once or twice-daily inhalation.

Manufactured by Cipla — one of India’s most respected and globally recognised pharmaceutical companies — Seroflo Rotacaps 100 mcg provide patients with an affordable, high-quality generic alternative to branded fluticasone-salmeterol combination products, delivering equivalent dual-action anti-inflammatory and bronchodilator therapy at a significantly more accessible price point. At our online pharmacy, we stock genuine Seroflo Rotacaps 100mcg products, giving patients convenient, discreet, and affordable access to this trusted entry-level combination respiratory therapy.

What Are Seroflo Rotacaps 100 mcg?

Seroflo Rotacaps 100 mcg are fixed-dose combination dry powder inhalation capsules containing fluticasone propionate 100 mcg and salmeterol 25mcg per capsule, manufactured by Cipla for use with a standard Rotahaler breath-activated device.

Each individually sealed capsule delivers a precise, pre-measured combination dose of two pharmacologically complementary respiratory medications — a potent inhaled corticosteroid preventer and a long-acting beta-2 adrenergic agonist bronchodilator — through a single breath-activated inhalation that requires no canister coordination, no propellant, and no complex device preparation.

The 100mcg fluticasone strength positions Seroflo Rotacaps 100 mcg as the entry-level option within the Seroflo Rotacaps range — appropriate for patients with mild-to-moderate persistent asthma who require low-dose inhaled corticosteroid coverage combined with long-acting bronchodilator support. This strength is particularly suitable for patients stepping up from low-dose ICS monotherapy, patients new to combination inhaler treatment, or those whose asthma severity warrants combination therapy at the lowest effective ICS dose.

Seroflo is Cipla’s well-established generic equivalent of the globally recognised Seretide brand — containing identical active ingredients at equivalent doses, manufactured to consistent pharmaceutical quality standards, and delivering clinically equivalent dual-action respiratory control at a considerably more affordable price.

How Seroflo Rotacaps 100 mcg Work?

Seroflo Rotacaps 100 mcg deliver two pharmacologically distinct, deeply complementary medications that address asthma pathophysiology from two critical and interconnected angles simultaneously.

Fluticasone Propionate 100 mcg — ICS Anti-inflammatory Component

Fluticasone propionate is among the most potent inhaled corticosteroids currently available in clinical respiratory practice. Even at the relatively low 100mcg dose present in Seroflo Rotacaps 100 mcg, fluticasone’s exceptional glucocorticoid receptor binding affinity and high lipophilicity deliver meaningful, clinically significant anti-inflammatory airway protection.

Fluticasone works by binding with high affinity to glucocorticoid receptors within airway epithelial and inflammatory cells — triggering comprehensive suppression of the inflammatory cascade that drives asthma symptoms. It suppresses the recruitment and activation of eosinophils, mast cells, basophils, and T-lymphocytes while simultaneously reducing the release of inflammatory mediators, cytokines, and chemokines that perpetuate bronchial hypersensitivity and mucosal oedema.

With consistent daily use, even low-dose fluticasone gradually transforms chronically inflamed, hypersensitive airways into more stable, resilient ones — reducing trigger sensitivity, decreasing exacerbation frequency, and building progressive long-term anti-inflammatory protection that strengthens over weeks of regular therapy.

Fluticasone’s particularly high lipophilicity means it remains localised within the airway tissue for extended periods — prolonging local anti-inflammatory duration while minimising systemic absorption and consequent whole-body corticosteroid exposure.

Salmeterol 25mcg — LABA Bronchodilator Component

Salmeterol is a long-acting beta-2 adrenergic agonist that complements fluticasone’s anti-inflammatory action by providing sustained bronchodilation lasting up to twelve hours from a single dose. By binding to beta-2 receptors in the airway smooth muscle and maintaining their activated, relaxed state throughout both waking and sleeping hours, salmeterol ensures airways remain consistently widened — reducing breathlessness, improving exercise tolerance, and preventing the nocturnal tightness and early morning wheeze that significantly disrupt asthma patients’ sleep and morning quality of life.

Salmeterol’s unique molecular structure — particularly its long lipophilic side chain — anchors it to the receptor site and sustains the bronchodilating effect for twelve hours, enabling twice-daily dosing that provides continuous around-the-clock airway relaxation.

Importantly, salmeterol must always be used alongside fluticasone in asthma management — as in Seroflo Rotacaps — never as standalone LABA monotherapy. The combination format ensures patients always receive both components simultaneously.

Seroflo Rotacaps 100 mcg vs Other Seroflo Rotacap Strengths

Conditions Treated with Seroflo Rotacaps 100 mcg

Seroflo Rotacaps 100 mcg are prescribed for respiratory conditions where low-dose combined anti-inflammatory and long-acting bronchodilator therapy delivers clinically meaningful improvements in symptom control:

• Mild-to-Moderate Persistent Asthma — The primary indication, providing entry-level combination ICS-LABA therapy for patients whose asthma is not adequately managed by low-dose inhaled corticosteroid monotherapy alone
• Step-Up from ICS Monotherapy — For patients currently on low-dose fluticasone, budesonide, or beclomethasone alone whose symptoms have progressed beyond single-agent control — Seroflo 100mcg represents the logical, guideline-recommended first combination step-up
• Nocturnal Asthma — Salmeterol’s twelve-hour bronchodilation provides reliable overnight airway protection — significantly reducing night-time coughing, breathlessness, and early morning chest tightness
• Exercise-Induced Bronchoconstriction — Regular twice-daily Seroflo 100mcg use helps prevent physical activity from triggering acute airway narrowing in susceptible asthma patients
• Allergic Asthma — Fluticasone’s potent anti-inflammatory action addresses allergen-driven airway inflammation while salmeterol maintains consistent bronchodilation throughout allergen exposure seasons
• Adolescent Asthma Management — The low-dose entry-level formulation is particularly appropriate for adolescent patients requiring combination therapy at the minimum effective ICS dose

Benefits of Seroflo Rotacaps 100 mcg

• Dual-action asthma control at the lowest combination dose — Simultaneously addresses airway inflammation and bronchospasm at entry-level ICS strength — maximising efficacy while minimising corticosteroid exposure
• Twelve-hour salmeterol bronchodilation — Consistent airway relaxation throughout day and night from twice-daily dosing
• Progressive anti-inflammatory protection — Low-dose fluticasone builds meaningful airway inflammation control over weeks of consistent use — reducing trigger sensitivity and exacerbation frequency
• Reduced nocturnal and early morning symptoms — Effective overnight bronchodilation eliminates the symptom pattern that most profoundly disrupts asthma patients’ sleep and morning functioning
• Breath-activated Rotahaler delivery — No canister coordination required — the Rotahaler releases powder automatically upon inhalation for consistent, reliable dosing
• Propellant-free dry powder format — Environmentally considerate delivery with no chemical propellants and no cold aerosol sensation
• Affordable entry-level combination therapy — Cipla’s consistent pharmaceutical quality at an accessible price point — significantly more affordable than branded equivalent products
• Simplified dual-medication regimen — One capsule replaces two separate inhalers — reducing device burden and improving daily treatment adherence

How to Use Seroflo Rotacaps 100 mcg?

1. Remove one Rotacap immediately before use — Never pre-prepare capsules — moisture rapidly degrades the powder once the seal is broken
2. Open the Rotahaler — Hold the device upright and rotate the barrel to open the capsule chamber
3. Insert the Rotacap — Place the capsule into the chamber with the transparent end facing downward
4. Close and pierce — Close the Rotahaler firmly and rotate the barrel fully in both directions until the capsule is pierced
5. Breathe out gently away from device — Exhale completely away from the mouthpiece — never exhale into the device
6. Seal your lips — Place the mouthpiece between your teeth and form a complete, airtight lip seal
7. Inhale forcefully and deeply — Breathe in as fast and as deeply as possible in a single strong breath — you may hear the capsule spinning
8. Hold your breath — Remove the Rotahaler and hold breath for ten full seconds before exhaling slowly
9. Check the capsule — Open the device and confirm the capsule is empty — repeat inhalation if powder remains
10. Discard the empty capsule — Remove and dispose of the used capsule after every dose
11. Rinse your mouth — Always rinse with water and spit immediately after every Seroflo Rotacap dose to prevent oral thrush

Important Usage Information

Use Twice Daily Without Fail — Seroflo Rotacaps 100 mcg must be taken consistently twice daily — typically morning and evening — regardless of symptom level. Never skip doses even on completely symptom-free days — the anti-inflammatory benefit depends on uninterrupted daily use.

This Is Not a Rescue Inhaler — Salmeterol’s slower onset means Seroflo Rotacaps cannot provide adequate rapid relief during sudden acute asthma attacks. Always keep a separate short-acting reliever inhaler such as salbutamol immediately accessible at all times.

Never Use Salmeterol Without Fluticasone in Asthma — Seroflo Rotacaps always deliver both components together — never use standalone LABA therapy without concurrent ICS coverage in asthma management.

Rinse Mouth After Every Dose — Always rinse thoroughly with water and spit after each inhalation to prevent oral thrush from fluticasone deposition in the oropharynx — even at the low 100mcg dose.

Inhale Forcefully — The Rotahaler requires a fast, forceful inhalation to disaggregate the powder and carry medication deep into the airways. A slow or gentle breath significantly reduces delivered dose efficiency.

Never Exhale Into the Device — Moisture from exhaled breath damages the powder and compromises dose accuracy — always exhale away from the mouthpiece before inhalation.

Consult Your Doctor If Symptoms Worsen — If asthma control deteriorates despite regular twice-daily Seroflo 100mcg use, contact your prescriber promptly — stepping up to a higher Seroflo strength may be clinically indicated.

Asthma Treatment Guides:- Asthma Inhalers: Types, Uses, Benefits & Complete Treatment Guide.

Common Mistakes to Avoid

• Pre-preparing capsules in advance — Only pierce each capsule immediately before use — advance preparation causes moisture damage and potency loss
• Inhaling too gently — Always inhale forcefully — the Rotahaler requires strong inhalation force to function correctly
• Skipping the mouth rinse — Never omit mouth rinsing after every dose — oral thrush risk exists even at low ICS doses
• Using as sole rescue medication — Never rely on Seroflo Rotacaps for acute emergency relief — always maintain a separate salbutamol rescue inhaler
• Exhaling into the device — Moisture from breath rapidly damages remaining powder — always exhale away from the mouthpiece
• Stopping when feeling well — Symptom absence reflects the medication working correctly — never discontinue independently
• Not checking capsule emptiness — Always verify complete capsule emptying after inhalation for full dose delivery

Frequently Asked Questions?

What is Seroflo Rotacaps 100 mcg used for?

Seroflo Rotacaps 100 mcg delivers low-dose combined fluticasone and salmeterol therapy for mild-to-moderate persistent asthma — providing dual anti-inflammatory and bronchodilator control through a single twice-daily breath-activated capsule inhalation.

Is Seroflo Rotacaps 100 mcg the same as Seretide?

Seroflo contains identical active ingredients — fluticasone propionate and salmeterol — at equivalent doses to Seretide. Manufactured by Cipla to consistent pharmaceutical standards, it is considered a clinically equivalent and significantly more affordable generic alternative.

Can Seroflo Rotacaps 100 mcg be used as a rescue inhaler?

No — salmeterol’s slow onset makes Seroflo unsuitable for acute symptom relief. Always keep a separate short-acting salbutamol reliever inhaler available for emergency use at all times.

How long does Seroflo Rotacaps 100 mcg take to work?

Salmeterol provides bronchodilation within fifteen to thirty minutes lasting up to twelve hours. Fluticasone’s full anti-inflammatory benefit builds progressively over days to weeks of consistent twice-daily use.

When should I step up from Seroflo 100 mcg to a higher strength?

If asthma symptoms remain inadequately controlled despite consistent twice-daily use of Seroflo 100 mcg, consult your doctor — stepping up to Seroflo Rotacaps 250mcg or another appropriate therapy may be clinically indicated.

Are Seroflo Rotacaps 100 mcg suitable for children?

Suitability and appropriate dosing for paediatric patients should always be confirmed with a paediatric respiratory specialist before commencing combination inhaler therapy.

Medical Disclaimer:-

The information provided on this page is for general informational purposes only and does not constitute medical advice, a clinical diagnosis, or a personalised treatment recommendation. Seroflo Rotacaps 100 mcg are prescription-only medications and must always be used under the direct guidance and supervision of a qualified healthcare professional. If you experience worsening respiratory symptoms, inadequate symptom control, or any unexpected side effects while using Seroflo Rotacaps 100mcg, please consult your doctor, respiratory specialist, or pharmacist without delay. Never adjust, discontinue, or substitute your prescribed combination inhaler therapy without first obtaining appropriate professional medical advice.

Related Medications:-

Hiflo Rotacaps 500 Mcg (Salmeterol & Fluticasone)

Seroflo Multihaler 250 (Salmeterol/Fluticasone)